Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Coherus Oncology
AddedFeb 17, 2024
UpdatedJul 4, 2026
Coherus Oncology

Coherus Oncology

Inactive

BioGenerics, Inc.: A Redwood City-based biotechnology and software company, founded in 2010.

HQ
Redwood City, CA, US
Founded
2010
Overview
Compare
Fundraising
Employees

BioGenerics, Inc. is a biotechnology and software company founded in 2010 and based in Redwood City, California. The company focuses on developing innovative biotechnological solutions and software products aimed at improving healthcare outcomes. Its core mission is to leverage advanced technology to create accessible and effective healthcare solutions for a global market.

Since its inception, BioGenerics has made significant strides in the biotech industry, contributing to advancements in healthcare technology. The company has garnered attention for its impactful products and services, establishing itself as a key player in the biotech and software sectors.

Coherus Oncology - Similar Companies

Bioregency logo

Bioregency

Genteric logo

Genteric

Geneicd logo

Geneicd

Biotech Holdings logo

Biotech Holdings

BioDatomics logo

BioDatomics

biodatomics.com

Cogent Biosciences logo

Cogent Biosciences

cogentbio.com

Bioinformatics logo

Bioinformatics

bioinfoinc.com

Adipogenix logo

Adipogenix

BridGene Biosciences logo

BridGene Biosciences

Drift Bio logo

Drift Bio

Coherus BioSciences logo

Coherus BioSciences

coherus.com

BioHealthonomics logo

BioHealthonomics

HBM Genomics logo

HBM Genomics

Station X logo

Station X

Genentech logo

Genentech

gene.com

Coherus Oncology - Quick Facts

Who are Coherus Oncology's competitors?

Companies similar to Coherus Oncology include Bioregency, Genteric, Geneicd and Biotech Holdings.

When was Coherus Oncology founded?

Coherus Oncology was founded in 2010.

Where is Coherus Oncology's headquarters located?

Coherus Oncology's headquarters is located in Redwood City, CA, US.

When was Coherus Oncology's last funding round?

Coherus Oncology's most recent funding round was for $3.8M (USD) in July 2011.

How much has Coherus Oncology raised to-date?

As of Jul 25, 2011, Coherus Oncology has raised a total of $4.7M (USD).

Coherus Oncology - Classification

Ownership
  • Private
Technology
  • Biotech
Geographic Exposure
  • United States
Revenue
  • Recurring
Customer
  • Enterprise
Main Product
  • Biotechnology
  • Software
Tags
  • SaaS
Unique IDs
  • secCik: 0001512762
  • ticker: CHRS
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541500Computer Systems Design and Related Services
  • 541000Professional, Scientific, and Technical Services
  • 541510Computer Systems Design and Related Services
  • 541511Custom Computer Programming Services
SIC
  • 7300Business Services
  • 7370Computer Programming, Data Processing, And Other Computer Related
  • 7371Computer Programming Services
Show 15 more industry codes
NAICS
  • 513200Software Publishers
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 510000Information
  • 620000Health Care and Social Assistance
  • 513000Publishing Industries
  • 541700Scientific Research and Development Services
  • 513210Software Publishers
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8000Health Services
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8730Research, Development, And Testing Services
  • 7372Prepackaged Software
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified
  • 8731Commercial Physical and Biological Research